MARKER THERAPEUTICS, INC. Increase (Decrease) in Deferred Charges
MARKER THERAPEUTICS, INC. (MRKR) reported Increase (Decrease) in Deferred Charges of $11.81 thousand for the 179-month period ending 2014-06-30, per its 10-Q filed 2014-08-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2015-04-15
- MARKER THERAPEUTICS, INC. increase (decrease) in deferred charges for the quarter ending 2013-12-31 was $645.00, a 84.05% decline year-over-year.
- MARKER THERAPEUTICS, INC. increase (decrease) in deferred charges for the quarter ending 2013-09-30 was $6.06K, a 30.91% decline year-over-year.
- MARKER THERAPEUTICS, INC. increase (decrease) in deferred charges for the quarter ending 2013-06-30 was $27.89K.
- MARKER THERAPEUTICS, INC. increase (decrease) in deferred charges for the quarter ending 2013-03-31 was -$10.59K.
- MARKER THERAPEUTICS, INC. increase (decrease) in deferred charges for fiscal 2013 was -$24.01K, a 565.28% decline from fiscal 2012.
- MARKER THERAPEUTICS, INC. increase (decrease) in deferred charges for fiscal 2012 was $5.16K.
- MARKER THERAPEUTICS, INC. increase (decrease) in deferred charges for fiscal 2011 was -$58.84K, a 189.31% decline from fiscal 2010.
- MARKER THERAPEUTICS, INC. increase (decrease) in deferred charges for fiscal 2010 was $65.89K.
| Period end | Increase (Decrease) in Deferred Charges 3 month | Increase (Decrease) in Deferred Charges 6 month | Increase (Decrease) in Deferred Charges 6 month as first filed | Increase (Decrease) in Deferred Charges 9 month | Increase (Decrease) in Deferred Charges 9 month as first filed | Increase (Decrease) in Deferred Charges 12 month | Increase (Decrease) in Deferred Charges 149 month | Increase (Decrease) in Deferred Charges 152 month | Increase (Decrease) in Deferred Charges 155 month | Increase (Decrease) in Deferred Charges 158 month | Increase (Decrease) in Deferred Charges 161 month | Increase (Decrease) in Deferred Charges 164 month | Increase (Decrease) in Deferred Charges 167 month | Increase (Decrease) in Deferred Charges 170 month | Increase (Decrease) in Deferred Charges 173 month | Increase (Decrease) in Deferred Charges 179 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-06-30 | $11.81K 10-Q · filed 2014-08-18 | |||||||||||||||
| 2013-12-31 | $645.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | $6.71K derived: sum of 2 quarters · filed 2015-04-15 | $34.60K derived: sum of 3 quarters · filed 2015-04-15 | -$24.01K 10-K/A · filed 2014-04-17 | -$11.81K 10-Q/A · filed 2014-05-21 | |||||||||||
| 2013-09-30 | $6.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-19 | $33.95K derived: sum of 2 quarters · filed 2014-11-19 | $23.37K 10-Q · filed 2014-11-19 | -$23.37K 10-Q · filed 2013-11-19 | $27.41K derived: sum of 4 quarters · filed 2014-11-19 | -$11.16K 10-Q · filed 2013-11-19 | ||||||||||
| 2013-06-30 | $27.89K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-08-18 | $17.31K 10-Q · filed 2014-08-18 | -$17.31K 10-Q · filed 2013-08-19 | $21.35K derived: sum of 3 quarters · filed 2014-08-18 | $30.12K derived: sum of 4 quarters · filed 2014-08-18 | -$5.10K 10-Q · filed 2013-08-19 | ||||||||||
| 2013-03-31 | -$10.59K 10-Q/A · filed 2014-05-21 | -$6.54K derived: sum of 2 quarters · filed 2014-05-21 | $2.23K derived: sum of 3 quarters · filed 2014-05-21 | -$1.60K derived: sum of 4 quarters · filed 2014-05-21 | $1.62K 10-Q/A · filed 2013-08-19 | |||||||||||
| 2012-12-31 | $4.04K derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-15 | $12.81K derived: sum of 2 quarters · filed 2013-11-19 | $8.99K derived: sum of 3 quarters · filed 2013-11-19 | $5.16K 10-K/A · filed 2014-04-17 | $12.20K 10-K · filed 2013-05-15 | |||||||||||
| 2012-09-30 | $8.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | $4.95K derived: sum of 2 quarters · filed 2013-11-19 | $1.12K 10-Q · filed 2013-11-19 | -$2.75K derived: sum of 4 quarters · filed 2013-11-19 | $8.16K 10-Q · filed 2012-11-19 | |||||||||||
| 2012-06-30 | -$3.83K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-08-19 | -$7.65K 10-Q · filed 2013-08-19 | -$11.52K derived: sum of 3 quarters · filed 2013-08-19 | -$15.39K derived: sum of 4 quarters · filed 2013-08-19 | -$612.00 10-Q/A · filed 2012-09-12 | |||||||||||
| 2012-03-31 | -$3.83K 10-Q/A · filed 2013-08-19 | -$7.70K derived: sum of 2 quarters · filed 2013-08-19 | -$11.56K derived: sum of 3 quarters · filed 2013-08-19 | $28.46K derived: sum of 4 quarters · filed 2013-08-19 | $3.21K 10-Q · filed 2012-05-21 | |||||||||||
| 2011-12-31 | -$3.87K derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-15 | -$7.74K derived: sum of 2 quarters · filed 2013-05-15 | $32.29K derived: sum of 3 quarters · filed 2013-05-15 | -$58.84K 10-K · filed 2013-05-15 | $7.04K 10-K · filed 2012-04-16 | |||||||||||
| 2011-09-30 | -$3.87K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19 | $36.16K derived: sum of 2 quarters · filed 2012-11-19 | -$54.97K 10-Q · filed 2012-11-19 | |||||||||||||
| 2011-06-30 | $40.03K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-12 | -$51.10K 10-Q/A · filed 2012-09-12 | ||||||||||||||
| 2011-03-31 | -$91.13K 10-Q · filed 2012-05-21 | |||||||||||||||
| 2010-12-31 | $65.89K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |